GlassScriptPhysician profile
Amy J Park
NPI 1053328625
$11,334.62
in general payments reported to CMS, 2019-2025
9 companies · $311 in 2025
The $311 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,746 · 2020: $2,294 · 2021: $1,171 · 2022: $543 · 2023: $348 · 2024: $921 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,580.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $8,359.25 | 2019-2021 | |
| Boston Scientific Corporation | $1,093.39 | 2019-2025 | Advantage System, Solyx Sis System, Axonics |
| Coloplast Corp | $829.52 | 2019-2025 | Saffron |
| Axonics, INC. | $483.73 | 2020-2024 | Axonics |
| Abbvie INC. | $223.05 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $107.09 | 2019 | |
| Medtronic, INC. | $106.89 | 2021-2025 | Interstim |
| Myovant Sciences INC. | $94.78 | 2022 | |
| Applied Medical Resources Corporation | $36.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.